D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea
· Delayed Price · Currency is KRW
82,000
+3,100 (3.93%)
Mar 10, 2026, 3:19 PM KST
D&D Pharmatech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 3,434,945 | 513,608 | - | - | - | - | |
| Enterprise Value | 3,403,112 | 494,061 | - | - | - | - | |
| Last Close Price | 78900.00 | 12150.00 | - | - | - | - | |
| PS Ratio | 410.73 | 44.91 | - | - | - | - | |
| PB Ratio | 45.87 | 7.38 | - | - | - | - | |
| P/TBV Ratio | 76.60 | 14.45 | - | - | - | - | |
| EV/Sales Ratio | - | 43.20 | - | - | - | - | |
| Debt / Equity Ratio | 0.09 | 0.14 | 0.15 | 1.47 | 0.32 | 0.03 | |
| Net Debt / Equity Ratio | -0.42 | -0.29 | -0.14 | 0.09 | -0.23 | -0.30 | |
| Net Debt / EBITDA Ratio | 1.26 | 1.04 | 0.83 | -0.03 | 0.51 | 0.95 | |
| Net Debt / FCF Ratio | 1.28 | 0.91 | 0.82 | -0.03 | 0.61 | 1.07 | |
| Asset Turnover | 0.09 | 0.13 | 0.22 | 0.00 | 0.01 | - | |
| Quick Ratio | 8.74 | 3.20 | 2.28 | 0.47 | 1.14 | 6.63 | |
| Current Ratio | 9.82 | 3.58 | 2.61 | 0.61 | 1.22 | 7.28 | |
| Return on Equity (ROE) | -47.71% | -47.25% | 9.29% | -174.72% | -43.71% | -38.23% | |
| Return on Assets (ROA) | -19.54% | -17.70% | -9.75% | -24.89% | -19.70% | -16.52% | |
| Return on Invested Capital (ROIC) | -68.60% | -51.56% | -30.26% | -108.81% | -65.13% | -80.88% | |
| Return on Capital Employed (ROCE) | -34.40% | -29.00% | -18.80% | -177.30% | -41.10% | -31.40% | |
| Earnings Yield | -1.01% | -5.57% | - | - | - | - | |
| FCF Yield | -0.71% | -4.32% | - | - | - | - | |
| Buyback Yield / Dilution | -144.62% | -8.08% | -16.38% | 2.05% | -12.66% | -118.38% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.